BioTime Appoints Adi Mohanty Chief Operating Officer

Mr. Mohanty's primary responsibilities will be to build BioTime's business through the development of its subsidiaries and through the further development and commercialization of BioTime's HyStem A -based products. Mr. Mohanty will report to Michael D. West, Ph.D., BioTime's Chief Executive Officer.

http://www.businesswire.com/news/home/20141229005141/en/BioTime-Appoints-Adi-Mohanty-Chief-Operating-Officer